Quantitative Histone Mass Spectrometry Identifies Elevated Histone H3 Lysine 27 (Lys27) Trimethylation in Melanoma
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Quantitative Histone Mass Spectrometry Identifies Elevated Histone H3 Lysine 27 (Lys27) Trimethylation in Melanoma
Authors
Keywords
-
Journal
MOLECULAR & CELLULAR PROTEOMICS
Volume 15, Issue 3, Pages 765-775
Publisher
American Society for Biochemistry & Molecular Biology (ASBMB)
Online
2016-03-01
DOI
10.1074/mcp.m115.053363
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- RUNX3promoter hypermethylation is frequent in leukaemia cell lines and associated with acute myeloid leukaemia inv(16) subtype
- (2015) Marcos R. H. Estécio et al. BRITISH JOURNAL OF HAEMATOLOGY
- Quantitative Proteomic Analysis of Histone Modifications
- (2015) He Huang et al. CHEMICAL REVIEWS
- Disruption of BRD4 at H3K27Ac-enriched enhancer region correlates with decreased c-Myc expression in Merkel cell carcinoma
- (2015) Deepanwita Sengupta et al. Epigenetics
- A systematic review and meta-analysis of runt-related transcription factor 3 gene promoter hypermethylation and risk of gastric cancer
- (2015) Yongxin Xia et al. Journal of Cancer Research and Therapeutics
- SAHA Regulates Histone Acetylation, Butyrylation, and Protein Expression in Neuroblastoma
- (2014) Guofeng Xu et al. JOURNAL OF PROTEOME RESEARCH
- The Bromodomain of Gcn5 Regulates Site Specificity of Lysine Acetylation on Histone H3
- (2014) Anne M. Cieniewicz et al. MOLECULAR & CELLULAR PROTEOMICS
- EZH2 Methyltransferase and H3K27 Methylation in Breast Cancer
- (2012) Kyung Hyun Yoo et al. International Journal of Biological Sciences
- RUNX family: Regulation and diversification of roles through interacting proteins
- (2012) Linda Shyue Huey Chuang et al. INTERNATIONAL JOURNAL OF CANCER
- EZH2 inhibition as a therapeutic strategy for lymphoma with EZH2-activating mutations
- (2012) Michael T. McCabe et al. NATURE
- EZH2 Mediates Epigenetic Silencing of Neuroblastoma Suppressor Genes CASZ1, CLU, RUNX3, and NGFR
- (2011) C. Wang et al. CANCER RESEARCH
- Aberrations of EZH2 in Cancer
- (2011) A. Chase et al. CLINICAL CANCER RESEARCH
- A quantitative proteomic analysis of FFPE melanoma
- (2011) Stephanie Byrum et al. JOURNAL OF CUTANEOUS PATHOLOGY
- The Polycomb complex PRC2 and its mark in life
- (2011) Raphaël Margueron et al. NATURE
- Less label, more free: Approaches in label-free quantitative mass spectrometry
- (2011) Karlie A. Neilson et al. PROTEOMICS
- Prognostic significance of RUNX3 expression in human melanoma
- (2010) Zhizhong Zhang et al. CANCER
- Expression and significance of Cx43 and E-cadherin in gastric cancer and metastatic lymph nodes
- (2010) Bo Tang et al. MEDICAL ONCOLOGY
- An oncogene–tumor suppressor cascade drives metastatic prostate cancer by coordinately activating Ras and nuclear factor-κB
- (2010) Junxia Min et al. NATURE MEDICINE
- An assessment of histone-modification antibody quality
- (2010) Thea A Egelhofer et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- The neuronal repellent SLIT2 is a target for repression by EZH2 in prostate cancer
- (2010) J Yu et al. ONCOGENE
- Regulation of RUNX3 Tumor Suppressor Gene Expression in Cutaneous Melanoma
- (2009) M. Kitago et al. CLINICAL CANCER RESEARCH
- Floxin, a resource for genetically engineering mouse ESCs
- (2009) Veena Singla et al. NATURE METHODS
- Enhancer of Zeste Homologue 2 (EZH2) Down-regulates RUNX3 by Increasing Histone H3 Methylation
- (2008) Satoshi Fujii et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Repression of E-cadherin by the polycomb group protein EZH2 in cancer
- (2008) Q Cao et al. ONCOGENE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started